Arca Biopharma (ABIO) Reports Q2 Loss of $0.43/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ABIO Hot Sheet
Join SI Premium – FREE
Arca Biopharma (NASDAQ: ABIO) reported Q2 EPS of ($0.43), versus ($0.69) reported last year.
For earnings history and earnings-related data on Arca Biopharma (ABIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oscar Health Inc. (OSCR) Tops Q3 EPS by 63c ; Offers Guidance
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- Cigna Corp. (CI) Tops Q3 EPS by 46c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
